Share of the traditional pharmaceutical business
This statistic explains the traditional pharmaceutical business as a percentage of leading pharmaceutical companies' total sales in 2009. Total sales of Pfizer+Wyeth reached approximately 68.6 billion U.S. dollars that year, of which 92 percent was traditional pharmaceutical business.